Propensity score matched evaluation of epoetin alfa and darbepoetin alfa utilization in patients with cancer receiving chemotherapy.

被引：1
|
作者：
Bailey, R. A.
Tunceli, O.
Singer, J.
Stephenson, J. J.
Senbetta, M.
机构：
[1] Centocor Ortho Biotech Serv, Horsham, PA USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16518
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Darbepoetin alfa is cost effective compared to epoetin alfa for treatment of anemia in cancer patients receiving chemotherapy.
    Glaspy, JA
    Tchekmedyian, NS
    Gupta, S
    BLOOD, 2002, 100 (11) : 874A - 875A
  • [2] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
    Nowrousian, Mohammad Resa
    ONCOLOGIST, 2006, 11 (05): : 535 - 536
  • [3] Utilization trends of epoetin alfa and darbepoetin alfa in adult patients with cancer receiving chemotherapy in community practice settings.
    Coletti, T
    Howell, JB
    Todoroff, K
    Gregory, KL
    Fastenau, JM
    BLOOD, 2004, 104 (11) : 413B - 413B
  • [4] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy" - In Reply
    Waltzman, Roger
    ONCOLOGIST, 2006, 11 (05): : 536 - 537
  • [5] Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Herrington, JD
    Davidson, SL
    Tomita, DK
    Green, L
    Smith, RE
    Boccia, RV
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (01) : 54 - 62
  • [6] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CANCER INPATIENTS RECEIVING CHEMOTHERAPY
    Vekeman, F.
    Bailey, R.
    Lafeuille, M. H.
    McKenzie, R. S.
    Herrera, A. D.
    Lefebvre, P.
    VALUE IN HEALTH, 2009, 12 (03) : A40 - A41
  • [7] Retrospective study of the appropriate utilization of epoetin alfa and darbepoetin alfa in cancer patients with anemia
    Wong, SF
    Brown, ML
    Sarkisian, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [8] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [9] Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting
    Vekeman, F.
    LaFeuille, M.
    Bailey, R.
    Piech, C. Tak
    McKenzie, R. S.
    Lefebvre, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa for Anemia Concomitant With Chemotherapy
    Berger, Ariel
    Lord, Claudia
    Corey-Lisle, Patricia K.
    Williams, G. Rhys
    Oster, Gerry
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1350 - 1363
12345